APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indomethacin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Indomethacin Market Outlook and Growth Opportunities 2026

23 December 2025190 pages

Choose your research edition.

Industry ResearchIndomethacin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Indomethacin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Indomethacin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indomethacin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Indomethacin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Indomethacin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Indomethacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Indomethacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indomethacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Indomethacin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Indomethacin market include Xinhua Pharma, Merck, Ratiopharm, Ouyi Pharma, Konch Pharma and Hotai Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Indomethacin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Indomethacin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Indomethacin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Indomethacin market size, projected growth trends, production technologies, key applications, and end-use industries.

Indomethacin Segment by Company

Xinhua Pharma

Merck

Ratiopharm

Ouyi Pharma

Konch Pharma

Hotai Pharma

Indomethacin Segment by Type

Indomethacin Capsule

Indomethacin Tablet

Indomethacin Suppository

Others

Indomethacin Segment by Application

Children

Adults

Indomethacin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Indomethacin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Indomethacin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Indomethacin significant trends, drivers, influence factors in global and regions.

6. To analyze Indomethacin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indomethacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indomethacin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indomethacin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indomethacin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Indomethacin industry.

Chapter 3: Detailed analysis of Indomethacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Indomethacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Indomethacin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Indomethacin Industry Trends Table 2. Indomethacin Industry Drivers Table 3. Indomethacin Industry Opportunities and Challenges Table 4. Indomethacin Industry Restraints Table 5. Global Indomethacin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Indomethacin Revenue Share by Company (2021-2026) Table 7. Global Indomethacin Sales Volume by Company (tons) & (2021-2026) Table 8. Global Indomethacin Sales Volume Share by Company (2021-2026) Table 9. Global Indomethacin Average Price (US$/kg) of Company (2021-2026) Table 10. Global Indomethacin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Indomethacin Key Company Manufacturing Base & Headquarters Table 12. Global Indomethacin Company, Product Type & Application Table 13. Global Indomethacin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Indomethacin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Indomethacin Capsule Table 18. Significant Companies of Indomethacin Tablet Table 19. Significant Companies of Indomethacin Suppository Table 20. Significant Companies of Others Table 21. Global Indomethacin Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Indomethacin Sales Volume by Type (2021-2026) & (tons) Table 23. Global Indomethacin Sales Volume by Type (2027-2032) & (tons) Table 24. Global Indomethacin Sales Volume Share by Type (2021-2026) Table 25. Global Indomethacin Sales Volume Share by Type (2027-2032) Table 26. Global Indomethacin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Indomethacin Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Indomethacin Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Indomethacin Sales Value Share by Type (2021-2026) Table 30. Global Indomethacin Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Children Table 32. Significant Companies of Adults Table 33. Global Indomethacin Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 34. Global Indomethacin Sales Volume by Application (2021-2026) & (tons) Table 35. Global Indomethacin Sales Volume by Application (2027-2032) & (tons) Table 36. Global Indomethacin Sales Volume Share by Application (2021-2026) Table 37. Global Indomethacin Sales Volume Share by Application (2027-2032) Table 38. Global Indomethacin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Indomethacin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Indomethacin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Indomethacin Sales Value Share by Application (2021-2026) Table 42. Global Indomethacin Sales Value Share by Application (2027-2032) Table 43. Global Indomethacin Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 44. Global Indomethacin Sales by Region (2021-2026) & (tons) Table 45. Global Indomethacin Sales Market Share by Region (2021-2026) Table 46. Global Indomethacin Sales by Region (2027-2032) & (tons) Table 47. Global Indomethacin Sales Market Share by Region (2027-2032) Table 48. Global Indomethacin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Indomethacin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Indomethacin Sales Value Share by Region (2021-2026) Table 51. Global Indomethacin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Indomethacin Sales Value Share by Region (2027-2032) Table 53. Global Indomethacin Market Average Price (US$/kg) by Region (2021-2026) Table 54. Global Indomethacin Market Average Price (US$/kg) by Region (2027-2032) Table 55. Global Indomethacin Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 56. Global Indomethacin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Indomethacin Sales by Country (2021-2026) & (tons) Table 58. Global Indomethacin Sales Market Share by Country (2021-2026) Table 59. Global Indomethacin Sales by Country (2027-2032) & (tons) Table 60. Global Indomethacin Sales Market Share by Country (2027-2032) Table 61. Global Indomethacin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Indomethacin Sales Value Market Share by Country (2021-2026) Table 63. Global Indomethacin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Indomethacin Sales Value Market Share by Country (2027-2032) Table 65. Xinhua Pharma Company Information Table 66. Xinhua Pharma Business Overview Table 67. Xinhua Pharma Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 68. Xinhua Pharma Indomethacin Product Portfolio Table 69. Xinhua Pharma Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 73. Merck Indomethacin Product Portfolio Table 74. Merck Recent Development Table 75. Ratiopharm Company Information Table 76. Ratiopharm Business Overview Table 77. Ratiopharm Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 78. Ratiopharm Indomethacin Product Portfolio Table 79. Ratiopharm Recent Development Table 80. Ouyi Pharma Company Information Table 81. Ouyi Pharma Business Overview Table 82. Ouyi Pharma Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 83. Ouyi Pharma Indomethacin Product Portfolio Table 84. Ouyi Pharma Recent Development Table 85. Konch Pharma Company Information Table 86. Konch Pharma Business Overview Table 87. Konch Pharma Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 88. Konch Pharma Indomethacin Product Portfolio Table 89. Konch Pharma Recent Development Table 90. Hotai Pharma Company Information Table 91. Hotai Pharma Business Overview Table 92. Hotai Pharma Indomethacin Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 93. Hotai Pharma Indomethacin Product Portfolio Table 94. Hotai Pharma Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Indomethacin Distributors List Table 98. Indomethacin Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Indomethacin Product Image Figure 2. Global Indomethacin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Indomethacin Sales (2021-2032) & (tons) Figure 5. Global Indomethacin Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Indomethacin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Indomethacin Capsule Image Figure 10. Indomethacin Tablet Image Figure 11. Indomethacin Suppository Image Figure 12. Others Image Figure 13. Global Indomethacin Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Indomethacin Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Indomethacin Sales Volume Share by Type (2021-2032) Figure 16. Global Indomethacin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Indomethacin Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Indomethacin Sales Value Share by Type (2021-2032) Figure 19. Children Image Figure 20. Adults Image Figure 21. Global Indomethacin Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 22. Global Indomethacin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Indomethacin Sales Volume Share by Application (2021-2032) Figure 24. Global Indomethacin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Indomethacin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Indomethacin Sales Value Share by Application (2021-2032) Figure 27. Global Indomethacin Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 28. Global Indomethacin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Indomethacin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Indomethacin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Indomethacin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Indomethacin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Indomethacin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Indomethacin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Indomethacin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Indomethacin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Indomethacin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Indomethacin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Indomethacin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Indomethacin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Indomethacin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Indomethacin Capsule
  • Indomethacin Tablet
  • Indomethacin Suppository
  • Others
Applications
  • Children
  • Adults
Companies covered
  • Xinhua Pharma
  • Merck
  • Ratiopharm
  • Ouyi Pharma
  • Konch Pharma
  • Hotai Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Indomethacin Sales Value (2021-2032)
  4. 1.2.2 Global Indomethacin Sales Volume (2021-2032)
  5. 1.2.3 Global Indomethacin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Indomethacin Market Dynamics
  1. 2.1 Indomethacin Industry Trends
  2. 2.2 Indomethacin Industry Drivers
  3. 2.3 Indomethacin Industry Opportunities and Challenges
  4. 2.4 Indomethacin Industry Restraints
3 Indomethacin Market by Company
  1. 3.1 Global Indomethacin Company Revenue Ranking in 2025
  2. 3.2 Global Indomethacin Revenue by Company (2021-2026)
  3. 3.3 Global Indomethacin Sales Volume by Company (2021-2026)
  4. 3.4 Global Indomethacin Average Price by Company (2021-2026)
  5. 3.5 Global Indomethacin Company Ranking (2024-2026)
  6. 3.6 Global Indomethacin Company Manufacturing Base and Headquarters
  7. 3.7 Global Indomethacin Company Product Type and Application
  8. 3.8 Global Indomethacin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Indomethacin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Indomethacin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Indomethacin Market by Type
  1. 4.1 Indomethacin Type Introduction
  2. 4.1.1 Indomethacin Capsule
  3. 4.1.2 Indomethacin Tablet
  4. 4.1.3 Indomethacin Suppository
  5. 4.1.4 Others
  6. 4.2 Global Indomethacin Sales Volume by Type
  7. 4.2.1 Global Indomethacin Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Indomethacin Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Indomethacin Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Indomethacin Sales Value by Type
  11. 4.3.1 Global Indomethacin Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Indomethacin Sales Value by Type (2021-2032)
  13. 4.3.3 Global Indomethacin Sales Value Share by Type (2021-2032)
5 Indomethacin Market by Application
  1. 5.1 Indomethacin Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Indomethacin Sales Volume by Application
  5. 5.2.1 Global Indomethacin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Indomethacin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Indomethacin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Indomethacin Sales Value by Application
  9. 5.3.1 Global Indomethacin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Indomethacin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Indomethacin Sales Value Share by Application (2021-2032)
6 Indomethacin Regional Sales and Value Analysis
  1. 6.1 Global Indomethacin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Indomethacin Sales by Region (2021-2032)
  3. 6.2.1 Global Indomethacin Sales by Region: 2021-2026
  4. 6.2.2 Global Indomethacin Sales by Region (2027-2032)
  5. 6.3 Global Indomethacin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Indomethacin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Indomethacin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Indomethacin Sales Value by Region (2027-2032)
  9. 6.5 Global Indomethacin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Indomethacin Sales Value (2021-2032)
  12. 6.6.2 North America Indomethacin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Indomethacin Sales Value (2021-2032)
  15. 6.7.2 Europe Indomethacin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Indomethacin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Indomethacin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Indomethacin Sales Value (2021-2032)
  21. 6.9.2 South America Indomethacin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Indomethacin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Indomethacin Sales Value Share by Country, 2025 VS 2032
7 Indomethacin Country-level Sales and Value Analysis
  1. 7.1 Global Indomethacin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Indomethacin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Indomethacin Sales by Country (2021-2032)
  4. 7.3.1 Global Indomethacin Sales by Country (2021-2026)
  5. 7.3.2 Global Indomethacin Sales by Country (2027-2032)
  6. 7.4 Global Indomethacin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Indomethacin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Indomethacin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Indomethacin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Indomethacin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Indomethacin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Indomethacin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Indomethacin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Indomethacin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Indomethacin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Indomethacin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Indomethacin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Indomethacin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Indomethacin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Indomethacin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Indomethacin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Indomethacin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Indomethacin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Indomethacin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Indomethacin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Indomethacin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Indomethacin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Indomethacin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Indomethacin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Indomethacin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Indomethacin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Indomethacin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Indomethacin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Indomethacin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Indomethacin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Indomethacin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Indomethacin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Indomethacin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Indomethacin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Indomethacin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Indomethacin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Indomethacin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Indomethacin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Indomethacin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Indomethacin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Indomethacin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Indomethacin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Indomethacin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Indomethacin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Indomethacin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Indomethacin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Indomethacin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Indomethacin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Indomethacin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Indomethacin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Indomethacin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Indomethacin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Indomethacin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Indomethacin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Indomethacin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Indomethacin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Indomethacin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Indomethacin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Indomethacin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Indomethacin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Indomethacin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Indomethacin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Indomethacin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Indomethacin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Indomethacin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Indomethacin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Indomethacin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Indomethacin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Indomethacin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Indomethacin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Indomethacin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Indomethacin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Indomethacin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Indomethacin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Indomethacin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Indomethacin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Indomethacin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Indomethacin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Indomethacin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Indomethacin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Indomethacin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Indomethacin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Indomethacin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Indomethacin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Indomethacin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Indomethacin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Indomethacin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xinhua Pharma
  2. 8.1.1 Xinhua Pharma Company Information
  3. 8.1.2 Xinhua Pharma Business Overview
  4. 8.1.3 Xinhua Pharma Indomethacin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xinhua Pharma Indomethacin Product Portfolio
  6. 8.1.5 Xinhua Pharma Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Indomethacin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Indomethacin Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Ratiopharm
  14. 8.3.1 Ratiopharm Company Information
  15. 8.3.2 Ratiopharm Business Overview
  16. 8.3.3 Ratiopharm Indomethacin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ratiopharm Indomethacin Product Portfolio
  18. 8.3.5 Ratiopharm Recent Developments
  19. 8.4 Ouyi Pharma
  20. 8.4.1 Ouyi Pharma Company Information
  21. 8.4.2 Ouyi Pharma Business Overview
  22. 8.4.3 Ouyi Pharma Indomethacin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ouyi Pharma Indomethacin Product Portfolio
  24. 8.4.5 Ouyi Pharma Recent Developments
  25. 8.5 Konch Pharma
  26. 8.5.1 Konch Pharma Company Information
  27. 8.5.2 Konch Pharma Business Overview
  28. 8.5.3 Konch Pharma Indomethacin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Konch Pharma Indomethacin Product Portfolio
  30. 8.5.5 Konch Pharma Recent Developments
  31. 8.6 Hotai Pharma
  32. 8.6.1 Hotai Pharma Company Information
  33. 8.6.2 Hotai Pharma Business Overview
  34. 8.6.3 Hotai Pharma Indomethacin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hotai Pharma Indomethacin Product Portfolio
  36. 8.6.5 Hotai Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Indomethacin Value Chain Analysis
  2. 9.1.1 Indomethacin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Indomethacin Sales Mode & Process
  6. 9.2 Indomethacin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Indomethacin Distributors
  9. 9.2.3 Indomethacin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst